Association between cartilage and bone biomarkers and incidence of radiographic knee osteoarthritis (RKOA) in UK females: a prospective study.

[1]  P. Garnero,et al.  Association of serum levels of aggrecan ARGS, NITEGE fragments and radiologic knee osteoarthritis in Tunisian patients. , 2012, Joint, bone, spine : revue du rhumatisme.

[2]  M. Englund,et al.  The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. , 2012, Osteoarthritis and cartilage.

[3]  J. McKeon,et al.  Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. , 2011, Osteoarthritis and cartilage.

[4]  L. Lohmander,et al.  Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains. , 2011, Osteoarthritis and cartilage.

[5]  J. Jordan,et al.  Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms? , 2011, Arthritis and rheumatism.

[6]  F. De Ceuninck,et al.  Recent progress toward biomarker identification in osteoarthritis. , 2011, Drug discovery today.

[7]  A R Poole,et al.  Application of Biomarkers in the Development of Drugs Intended for the Treatment of Osteoarthritis OARSI FDA Osteoarthritis Biomarkers Working Group , 2011 .

[8]  M. Rivera-Bermúdez,et al.  Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. , 2011, Osteoarthritis and cartilage.

[9]  M. Englund,et al.  Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis , 2010, Arthritis research & therapy.

[10]  G. Livshits,et al.  Outlines of the biochemistry of osteoarthritis. , 2010, Current rheumatology reviews.

[11]  A. Fosang,et al.  Identifying the human aggrecanase. , 2010, Osteoarthritis and cartilage.

[12]  F. Cicuttini,et al.  Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure , 2010, Annals of the rheumatic diseases.

[13]  T. Kepler,et al.  First Qualification Study of Serum Biomarkers as Indicators of Total Body Burden of Osteoarthritis , 2010, PloS one.

[14]  M. El-Arman,et al.  Aggrecan and Cartilage Oligomeric Matrix Protein in Serum and Synovial Fluid of Patients with Knee Osteoarthritis , 2010, HSS Journal.

[15]  A. Mündermann,et al.  Change in serum COMP concentration due to ambulatory load is not related to knee OA Status , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[16]  F. Williams.  Biomarkers: in combination they may do better , 2009, Arthritis research & therapy.

[17]  Mads Nielsen,et al.  Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers , 2009, Arthritis research & therapy.

[18]  J. Singer,et al.  Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. , 2009, Arthritis and rheumatism.

[19]  Naoto Endo,et al.  Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey , 2009, Journal of Bone and Mineral Metabolism.

[20]  L. Lohmander,et al.  Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases. , 2009, Osteoarthritis and cartilage.

[21]  A. Reddi,et al.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis , 2009, Biomarker insights.

[22]  C. Christiansen,et al.  Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial. , 2008, Osteoarthritis and cartilage.

[23]  M. Karsdal,et al.  Patients with rheumatoid arthritis have an altered circulatory aggrecan profile , 2008, BMC musculoskeletal disorders.

[24]  B. Nicklas,et al.  Inflammatory Biomarkers and Physical Function in Older, Obese Adults with Knee Pain and Self‐Reported Osteoarthritis After Intensive Weight‐Loss Therapy , 2008, Journal of the American Geriatrics Society.

[25]  Ali Guermazi,et al.  Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study , 2007, Arthritis research & therapy.

[26]  P. Delmas,et al.  Biological markers in osteoarthritis , 2007, Nature Clinical Practice Rheumatology.

[27]  S. Garstang,et al.  Osteoarthritis: Epidemiology, Risk Factors, and Pathophysiology , 2006, American journal of physical medicine & rehabilitation.

[28]  T. Spector,et al.  The heritable determinants of cartilage oligomeric matrix protein. , 2006, Arthritis and rheumatism.

[29]  S. Clarke,et al.  Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. , 2004, Arthritis and rheumatism.

[30]  J. Jordan.  Cartilage oligomeric matrix protein as a marker of osteoarthritis. , 2004, The Journal of rheumatology. Supplement.

[31]  Alexander Fraser,et al.  Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. , 2003, Arthritis and rheumatism.

[32]  F. Luyten,et al.  Osteoarthritis and osteoporosis: Clinical and research evidence of inverse relationship , 2003, Aging clinical and experimental research.

[33]  T. Spector,et al.  Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. , 2002, Arthritis and rheumatism.

[34]  M. Dougados,et al.  Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. , 2002, Arthritis and rheumatism.

[35]  S. Trattnig,et al.  Anatomy, Biochemistry, and Physiology of Articular Cartilage , 2000, Investigative radiology.

[36]  A. Poole,et al.  Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. , 1999, Arthritis and rheumatism.

[37]  C. White,et al.  Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. , 1998, Arthritis and rheumatism.

[38]  T. Spector,et al.  Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. , 1997, Arthritis and rheumatism.

[39]  D. Heinegård,et al.  Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. , 1994, Annals of the rheumatic diseases.

[40]  T. Spector,et al.  The relationship of obesity, fat distribution and osteoarthritis in women in the general population: the Chingford Study. , 1993, The Journal of rheumatology.

[41]  A. Mobasheri,et al.  Biomarkers of Osteoarthritis: A Review of Recent Research Progress on Soluble Biochemical Markers, Published Patents and Areas for Future Development , 2011 .

[42]  L. Ferrucci,et al.  Serum protein signatures detect early radiographic osteoarthritis. , 2009, Osteoarthritis and cartilage.

[43]  G. Gold,et al.  Atlas of individual radiographic features in osteoarthritis, revised. , 2007, Osteoarthritis and cartilage.

[44]  Nigel Arden,et al.  Osteoarthritis: epidemiology. , 2006, Best practice & research. Clinical rheumatology.

[45]  A. Yee,et al.  Structure and function of aggrecan , 2002, Cell Research.

[46]  P. Delmas,et al.  Biochemical Measurements of Bone Turnover in Children and Adolescents , 2000, Osteoporosis International.

[47]  M Lequesne,et al.  Atlas of individual radiographic features in osteoarthritis. , 1995, Osteoarthritis and cartilage.